Why Can Epilepsy Care Depend So Much on Where You Live?

Epilepsy occurs in every region of the world, but the route from a first seizure to diagnosis, treatment, specialist review and long-term follow-up can look very different depending on where a person lives.

Geography can shape the whole pathway

In some health systems, primary care can recognise common epilepsies, essential antiseizure medicines are continuously available, and referral to neurology, EEG and MRI is relatively straightforward. Elsewhere, people may travel long distances for basic assessment, face medicine shortages, pay substantial out-of-pocket costs or have no realistic access to specialist diagnostics.

Rural and urban differences are a recurring pattern

Global treatment-gap research repeatedly finds larger gaps in rural and remote settings. Distance, transport cost, fewer trained clinicians, weaker referral systems, medicine supply problems and concentration of diagnostic equipment in major cities can all contribute.

This does not mean every rural area has poor care or every city has good care. The point is that geography can affect how quickly someone reaches the right level of service and whether care remains continuous.

The neurological workforce is very unevenly distributed

WHO’s 2025 Global Status Report on Neurology describes major international disparities in the neurological workforce. Low-income countries have dramatically fewer neurologists per population than high-income countries, while specialist services are often concentrated in urban referral centres.

Epilepsy care therefore cannot be built around neurologists alone. In many settings, primary-care clinicians, nurses and other non-specialist health workers are essential to diagnosis, medication management, follow-up and referral.

Medicine access can depend on the health system, not only the prescription

A medicine may be clinically appropriate and still be practically inaccessible. Barriers can include stock-outs, limited formularies, cost, poor distribution, distance to pharmacies, lack of insurance coverage or inconsistent public-sector supply.

For long-term epilepsy treatment, continuity matters. Repeated interruptions can undermine seizure control even when the correct medicine has already been identified.

Diagnostic access is also unequal

Routine EEG, ambulatory EEG, long-term video-EEG, MRI and epilepsy-protocol MRI are not equally available worldwide. In some regions even a basic EEG requires travel to a distant centre; in others, advanced imaging and presurgical testing are available within specialist networks.

This matters because diagnostic uncertainty can prolong inappropriate treatment, delay recognition of drug-resistant epilepsy, or prevent identification of a structural or genetic cause.

Advanced epilepsy treatment is especially concentrated

Presurgical assessment, stereo-EEG, epilepsy surgery, VNS, DBS and other advanced treatments require specialist teams, equipment and long-term follow-up. Their availability is concentrated in relatively few centres worldwide.

Two people with similar drug-resistant epilepsy can therefore face very different options depending on whether they live near a tertiary epilepsy centre, whether referral pathways exist and whether care is publicly funded or affordable.

Income level is not the only dividing line

High-income countries can also have geographic inequalities, long waiting times, insurance restrictions, fragmented referral systems or limited access to advanced epilepsy centres. National wealth does not guarantee equal access within a country.

Likewise, some lower-resource settings have developed effective primary-care epilepsy programmes that improve access without requiring sophisticated technology for every patient.

Conflict, migration and disasters can break continuity

Where people are displaced by conflict, disaster or migration, the main problem may not be diagnosis but continuity: records are lost, medicines run out, brands or formulations change, and established clinical relationships disappear. Epilepsy care therefore depends partly on resilient supply chains and portable treatment information.

Stigma and culture can change care-seeking

Health-system access is only one part of the picture. In some communities, epilepsy may still be interpreted through spiritual, moral or supernatural explanations. Traditional healers, family beliefs and fear of discrimination can influence whether and when a person seeks biomedical care.

Respectful epilepsy programmes need to address misinformation without assuming that one cultural model or one health system is the global default.

What better access looks like

Improving geographical equity means more than building specialist centres. It can include reliable essential-medicine supply, training primary-care workers, clear referral criteria, tele-neurology where appropriate, better transport and outreach, access to EEG and MRI when clinically needed, and pathways to tertiary care for drug-resistant epilepsy.

Sources

Evidence checked: September 2026.